Eton Pharmaceuticals, Inc.ETONNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
27.16%
↑ 147% above average
Average (33q)
-57.94%
Historical baseline
Range
High:263.64%
Low:-650.00%
Volatility
-1576.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 27.16% |
| Q2 2025 | -64.27% |
| Q1 2025 | -155.46% |
| Q4 2024 | -194.63% |
| Q3 2024 | 120.17% |
| Q2 2024 | -280.95% |
| Q1 2024 | 64.04% |
| Q4 2023 | -289.33% |
| Q3 2023 | -112.50% |
| Q2 2023 | 263.64% |
| Q1 2023 | -375.00% |
| Q4 2022 | 130.77% |
| Q3 2022 | -109.68% |
| Q2 2022 | 71.82% |
| Q1 2022 | -650.00% |
| Q4 2021 | 116.67% |
| Q3 2021 | -200.00% |
| Q2 2021 | -138.10% |
| Q1 2021 | 165.63% |
| Q4 2020 | -3.23% |
| Q3 2020 | -34.78% |
| Q2 2020 | 54.00% |
| Q1 2020 | -233.33% |
| Q4 2019 | 46.43% |
| Q3 2019 | -55.56% |
| Q2 2019 | 57.14% |
| Q1 2019 | -31.25% |
| Q4 2018 | 38.46% |
| Q3 2018 | 5.45% |
| Q2 2018 | -1.85% |
| Q1 2018 | 73.13% |
| Q4 2017 | -302.00% |
| Q3 2017 | 27.54% |
| Q2 2017 | 0.00% |